Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10501731 Degradable clostridial toxins

Patent 10501731 was granted and assigned to Allergan, Inc. on December, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 9 Dec, 2023

"Add patent abstract"

edited on 9 Dec, 2023

Edits made to:

Article (+290 characters)

Article

Patent abstract

The specification discloses Clostridial toxins or Clostridial toxin chimeras comprising an inactivation cleavage site, polynucleotide molecules encoding such toxins or chimeras, compositions comprising such toxins or chimeras, and method of producing such toxins or chimeras.

Edits on 7 Dec, 2023

"update inverses"

edited on 7 Dec, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11833185 Anti-neurodegenerative therapeutic, method of manufacture, and use

0

Edits on 3 Oct, 2023

"Add patent inventor(s)"

edited on 3 Oct, 2023

Edits made to:

Infobox (+6 properties)

Infobox

Patent Inventor Names

Ester Fernandez-Salas0

Joseph Francis0

Kei Roger Aoki0

Lance E. Steward0

Marcella A. Gilmore0

Sanjiv Ghanshani0

Edits on 26 Jul, 2023

"update inverses"

edited on 26 Jul, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11707510 Nucleic acid-based botulinum neurotoxin for therapeutic use

0

Edits on 29 Apr, 2023

"update citations for inverse infoboxes"

edited on 29 Apr, 2023

Infobox

Patent Citations Received

US Patent 11248218 Botulinum neurotoxin and its derivatives

0

Edits on 28 Sep, 2022

"Entity importer update"

edited on 28 Sep, 2022

Infobox

Is a

0

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

105017310

Date of Patent

December 10, 2019

0

Patent Application Number

158455720

Date Filed

December 18, 2017

0

Patent Citations Received

US Patent 11248218 Botulinum neurotoxin and its derivatives

0

US Patent 11286473 Botulinum neurotoxin and its derivatives

0

US Patent 11434265 Chimeric neurotoxins

0

Patent Primary Examiner

Iqbal H Chowdhury

0

Edits on 25 Sep, 2022

"update citations for inverse infoboxes"

edited on 25 Sep, 2022

Infobox

Patent Citations Received

US Patent 11248218 Botulinum neurotoxin and its derivatives

0

Edits on 7 Sep, 2022

"update inverses"

edited on 7 Sep, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11434265 Chimeric neurotoxins

Edits on 30 Mar, 2022

"update inverses"

edited on 30 Mar, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent citations received

US Patent 11286473 Botulinum neurotoxin and its derivatives

Edits on 16 Feb, 2022

"update inverses"

edited on 16 Feb, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent citations received

US Patent 11248218 Botulinum neurotoxin and its derivatives

Edits on 31 Jan, 2022

"Created via: Entity Importer"

created this topic on 31 Jan, 2022

Edits made to:

Infobox (+9 properties)

‌

US Patent 10501731 Degradable clostridial toxins

Infobox

Is a

Patent applicant

Current assignee

Patent jurisdiction

United States Patent and Trademark Office

Patent number

10501731

Date of patent

December 10, 2019

Patent application number

15845572

Date Filed

December 18, 2017

Patent primary examiner

Iqbal H Chowdhury

Find more entities like US Patent 10501731 Degradable clostridial toxins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.